STOCKHOLDERS’ EQUITY (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Grants	1,166,930
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding at Beginning of Year	3,700,000
Number of Options, Grants	1,167,000
Number of Options, Exercised	0
Number of Option, Forfeited/cancelled/expired	100,000
Number of Options, Balance at End of Year	4,767,000	3,700,000
Number of Options, Vested and expected to vest	4,628,000
Number of Options, Unvested	1,367,000
Number of Options, Exercisable	3,400,000
Weighted-Average Exercise Price, Outstanding at Beginning of Year (in dollars per share)	$ 2.03
Weighted-Average Exercise Price, Grants (in dollars per share)	1.9
Weighted-Average Exercise Price, Exercised (in dollars per share)	0
Weighted-Average Exercise Price, Forfeited/cancelled/expired (in dollars per share)	7.5
Weighted-Average Exercise Price, Balance at End of Year (in dollars per share)	1.89	$ 2.03
Weighted-Average Exercise Price, Vested and expected to vest (in dollars per share)	1.88
Weighted-Average Exercise Price, Unvested (in dollars per share)	1.92
Weighted-Average Exercise Price, Exercisable (in dollars per share)	$ 1.87
Weighted-Average Remaining Contractual Term, Outstanding (in years)	5 years 1 month 13 days	4 years 2 months 16 days
Weighted-Average Remaining Contractual Term, Vested and expected to vest (in years)	4 years 11 months 26 days
Weighted-Average Remaining Contractual Term, Unvested (in years)	9 years 7 months 2 days
Weighted-Average Remaining Contractual Term, Exercisable (in years)	3 years 3 months 25 days
Aggregate Intrinsic Value, Vested and expected to vest	$ 588,090
Aggregate Intrinsic Value, Unvested	0
Aggregate Intrinsic Value, Exercisable	588,090
Aggregate Intrinsic Value, Outstanding at End of Year	$ 588,090	$ 3,675,000